The Hill: AstraZeneca vaccine likely won’t be authorized in US until April
The coronavirus vaccine developed by AstraZeneca and Oxford University is not likely to be authorized for use in the U.S. until April, a top Trump administration health official said Wednesday.
After the UK authorized this vaccine for emergency use today, there was hope the United States wouldn’t be far behind. But then came this discouraging news.
